Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection

Journal of Virology
Kun-Wei ChanXiang-Peng Kong

Abstract

Elucidating the structural basis of antibody (Ab) gene usage and affinity maturation of vaccine-induced Abs can inform the design of immunogens for inducing desired Ab responses in HIV vaccine development. Analyses of monoclonal Abs (MAbs) encoded by the same immunoglobulin genes at different stages of maturation can help to elucidate the maturation process. We have analyzed four human anti-V3 MAbs with the same VH1-3*01 and VL3-10*01 gene usage. Two MAbs, TA6 and TA7, were developed from a vaccinee in the HIV vaccine phase I trial DP6-001 with a polyvalent DNA prime/protein boost regimen, and two others, 311-11D and 1334, were developed from HIV-infected patients. The somatic hypermutation (SHM) rates in VH of vaccine-induced MAbs are lower than in chronic HIV infection-induced MAbs, while those in VL are comparable. Crystal structures of the antigen-binding fragments (Fabs) in complex with V3 peptides show that these MAbs bind the V3 epitope with a new cradle-binding mode and that the V3 β-hairpin lies along the antigen-binding groove, which consists of residues from both heavy and light chains. Residues conserved from the germ line sequences form specific binding pockets accommodating conserved structural elements of the V3 ...Continue Reading

References

Aug 8, 1991·Nature·J Foote, C Milstein
May 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C J Paige, G E Wu
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M K GornyS Zolla-Pazner
Jan 1, 1969·Advances in Immunology·G W Siskind, B Benacerraf
Apr 14, 1983·Nature·S Tonegawa
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·N N TengH S Kaplan
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J M RiniI A Wilson
Jun 13, 1997·Science·G J WedemayerR C Stevens
May 13, 2003·Nature Structural Biology·Yili LiRoy A Mariuzza
Jul 1, 1964·Biochemistry·H N EISEN, G W SISKIND
Feb 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ana CauerhffBradford C Braden
Jun 25, 2004·Nucleic Acids Research·Rajarshi MaitiDavid S Wishart
Nov 15, 2005·Science·Chih-chin HuangPeter D Kwong
Feb 20, 2007·Immunity·Thomas TillerHedda Wardemann
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Jul 14, 2010·Nature Structural & Molecular Biology·Xunqing JiangXiang-Peng Kong
Nov 2, 2013·Science·Jean-Philippe JulienIan A Wilson
Feb 7, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fleur S van de BovenkampYoann Rombouts
Feb 17, 2018·Frontiers in Immunology·Arjun K Mishra, Roy A Mariuzza

❮ Previous
Next ❯

Citations

Feb 6, 2020·Japanese Journal of Infectious Diseases·Yu KakuShuzo Matsushita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.